A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers.
© 2023 Center For Technology Licensing. Ithaca: 395 Pine Tree Road, Suite 310, Ithaca, NY 14850 | 607-254-4698. WCM: 1155 York Avenue, New York, NY 10065 | 646-962-7045. Contact
©️2022 Cornell University. Web Accessibility Assistance | Privacy Policy